Reassessing cancer risk with GLP-1 receptor agonists: a comprehensive meta-analysis of gastrointestinal malignancies. - Wali AF; Rangraze I; Khan S; Mufti UB; El-Tanani M; Rizzo M (Frontiers in pharmacology, 2026)